{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:30:17Z","timestamp":1789428617695,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.vaccine.2010.09.090","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T14:47:22Z","timestamp":1286808442000},"page":"8183-8188","source":"Crossref","is-referenced-by-count":33,"title":["CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-\u03b3 at 5\u20137 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses"],"prefix":"10.1016","volume":"28","author":[{"given":"Patr\u00edcia C.C.","family":"Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Rudersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Galler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna C.","family":"Bonaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon Gilsepp Veloso de","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Mudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva G.","family":"Rakasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.09.090_bib0005","unstructured":"WHO. Assessment of yellow fever epidemic risk- a decision- making tool for preventive imunization campaigns. Weekly epidemiological record 2007; 18(82):153\u2013160."},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.090_bib0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"issue":"13","key":"10.1016\/j.vaccine.2010.09.090_bib0015","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.090_bib0020","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.090_bib0025","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.vaccine.2010.09.090_bib0030","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","article-title":"Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination","volume":"26","author":"Martins","year":"2008","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2010.09.090_bib0035","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2009.07.028","article-title":"expression and NK cell activation after human yellow fever vaccination","volume":"27","author":"Neves","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.090_bib0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03317.x","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?","volume":"148","author":"Martins","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.090_bib0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2008.02.007","article-title":"Detection of Th1\/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay","volume":"42","author":"Santos","year":"2008","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.vaccine.2010.09.090_bib0115","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques","volume":"84","author":"Bonaldo","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.09.090_bib0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-4-115","article-title":"Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes","volume":"4","author":"Bonaldo","year":"2007","journal-title":"Virol J"},{"issue":"10","key":"10.1016\/j.vaccine.2010.09.090_bib0060","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.090_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cytogfr.2009.02.004","article-title":"Interferon-gamma: a historical perspective","volume":"20","author":"Billiau","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.090_bib0070","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.090_bib0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1993.1015","article-title":"The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice","volume":"192","author":"Schlesinger","year":"1993","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.090_bib0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1099\/0022-1317-76-1-217","article-title":"Neutralizing F(ab\u2019)2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis","volume":"76","author":"Schlesinger","year":"1995","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.090_bib0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou","year":"2009","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.090_bib0090","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.4049\/jimmunol.0901571","article-title":"Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells","volume":"183","author":"Devilder","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2010.09.090_bib0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.micinf.2004.12.009","article-title":"Antiviral reactivities of gamma-delta T cells","volume":"7","author":"Poccia","year":"2005","journal-title":"Microbes Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2010.09.090_bib0100","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1128\/JVI.00274-06","article-title":"Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection","volume":"80","author":"Shrestha","year":"2006","journal-title":"J Virol"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2010.09.090_bib0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1574-695X.2010.00663.x","article-title":"Gamma-delta T cells promote the maturation of dendritic cells during West Nile virus infection","volume":"59","author":"Fang","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"August (35)","key":"10.1016\/j.vaccine.2010.09.090_bib0110","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1016\/j.vaccine.2010.06.052","article-title":"Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development","volume":"28","author":"Franco","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10014325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T11:13:17Z","timestamp":1559733197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10014325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":22,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0264410X10014325"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}